Case Report Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.46439/ophthalmology.3.021
Visual field defect as an idiosyncratic reaction to topiramate
Neelakshi Bhagat1, Lekha Mukkamala1, Paul D. Langer1,*
- 1Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA
Corresponding Author
Paul D. Langer, planger@njms.rutgers.edu
Received Date: October 09, 2020
Accepted Date: February 10, 2021
Citation:
Bhagat N, Mukkamala L, Langer PD. Visual field defect as an idiosyncratic reaction to topiramate. Arch Clin Exp Ophthalmol 2021; 3(1):4-7.
Copyright: © 2021 Bhagat N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Visual field defect as an idiosyncratic reaction to topiramate
Topiramate is an increasingly popular medication used in the treatment of migraines, seizures, and other neurologic disorders. Its several mechanisms of action include enhancement of postsynaptic gamma-aminobutyric acid (GABA) receptor activity (an inhibitory neurotransmitter) and mild inhibition of carbonic anhydrase isoenzymes.